At M.C.I., we are committed to R&D to deliver innovative products of high quality and scientifically supported for preserving and improving the animals’ health, well-being, and performance, with benefit to their owner as well.

The R&D department comprises scientific experts and researchers across numerous science and veterinary medicine disciplines.

Our scientists use the latest research technologies to focus on improving and developing new products and processes to meet customer and market needs.

We apply our research to various animal species, therapeutic areas, and geographic regions. Our projects are mainly oriented toward combined vaccines, recombinant vaccines, viral vector vaccines, and subunit vaccines.

Our research is fueled by internal discovery efforts and partnerships with international organizations, N.G.O.s, and academic institutions.

By publishing its scientific work, M.C.I. participates actively in advancing research in the animal health sector.